Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,731 public trials 1,770 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

NCT03990896

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • UCSF Medical Center-Mission Bay/Benioff Children's Hospital San Francisco, California, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details
Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

NCT01042379

Conditions
Angiosarcoma, Breast Cancer, Breast Diseases, +24 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of California - Davis, Comprehensive Cancer Center Davis, California, United States
View all 42 locations
View Trial Details
Recruiting

Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

NCT07195344

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancers, +4 more
Locations
  • Institut de Cancérologie de l'Ouest - Site Angers Angers, France
  • Centre Georges François Leclerc Dijon, France
  • Centre Oscar Lambret Lille, France
  • Institut Paoli Calmettes Marseille, France
View Trial Details
Recruiting

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

NCT06905301

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Novartis Investigative Site Pskov, Russia
  • Novartis Investigative Site Moscow, Russia
  • Novartis Investigative Site Saint Petersburg, Russia
  • Novartis Investigative Site Saint Petersburg, Russia
View Trial Details

Related conditions